IImpact of Clinical and Biochemical Variables on Mortality and Morbidity of Patients With Alcohol Withdrawal Syndrome Under Treatment According to the CIWA-AR Scale"
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 195
- 试验地点
- 1
- 主要终点
- Death
研究概览
简要总结
The goal of this observational study is to describe the impact measured through the Odds Ratio (OR) of different variables of clinical and biochemical alterations on the duration of the syndrome alcohol withdrawal patients measured in days of symptoms and stay; it could include any patients with a diagnosis of admission of alcohol withdrawal syndrome (AWS) who have been treated in the department of Internal Medicine for 5 years.
The main question it aims to answer is: What is the relationship between the different clinical, biochemical, and hematic factors on the duration of symptoms, morbidity, and mortality in individuals with alcohol syndrome withdrawal?
• If the patient has a greater number of risk factors, such as advanced age, a long and chronic history of alcohol consumption, the type of distillate consumed, as well as the deterioration of liver function and presence of leukocytosis and neutrophilia, then it is postulated that the duration of alcohol withdrawal syndrome will be longer.
Clinical records will be used to describe the proportion of complications associated with alcohol withdrawal syndrome including pneumonia bronchial aspiration, seizures, need for mechanical ventilation, digestive tract hemorrhage, toxic-alcoholic hepatitis, and pancreatitis.
详细描述
Clinical records (files) of patients with a diagnosis of admission of alcohol withdrawal syndrome (AAS) who have been treated in the Department of Internal Medicine for 5 years.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical records of patients, both genders, over 18 years of age with Alcohol Withdrawal Syndrome according to the criteria for alcohol withdrawal.
- •Clinical records of candidates for admission for neurological monitoring and with criteria for use of sedative drugs according to the CIWA-Ar scale
- •Clinical records of patients containing the CIWA-Ar scale score at diagnosis
排除标准
- •Clinical records of patients who already have a history of seizures or epilepsy
- •Clinical records of diabetic patients with diabetic ketoacidosis
- •Clinical records of patients who have not received any type of sedative treatment
- •Clinical records of patients with chronic liver failure or liver cirrhosis
- •Clinical records of patients with chronic liver disease with signs of hepatic encephalopathy
- •Clinical records of patients with related toxic-alcoholic hepatitis
- •Clinical records of patients with a life expectancy of less than 24 hours due to associated complications such as head trauma or other associated complications
- •Clinical records of patients who require intubation and mechanical ventilation upon admission
- •Clinical records of patients who have a vascular event that modifies the neurological evaluation
- •Clinical records of patients who before admission show psychomotor alteration or neurological deterioration that modifies the neurological evaluation such as the presence of Wernicke's encephalopathy
结局指标
主要结局
Death
时间窗: 6 months
Permanent cessation of all vital functions of an organism, including irreversible stopping of the heart and breathing
Morbidity
时间窗: 6 months
Any type of complication present during the analysis period that complicates the resolution of the condition, including serious situations.
次要结局
- Hospital stay(6 months)
- Duration of symptoms(6 months)
研究者
Christian Omar Ramos-Peñafiel, MD, PhD
Principal investigator
Hospital General de Mexico